| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |